...with data available in early 2023. The series A provides runway to mid-2023. New investors Morningside Venture Investments...
...and more Corporate partners: N/A Number of employees: 10-20 Funds raised: $84.5 million Investors: Forbion, Morningside Venture Investments...

...School. On Jan. 7, Apic raised $40 million in a series A round led by Morningside Venture Investments...
...Massachusetts Medical School Corporate partners: Undisclosed Number of employees: Undisclosed Funds raised: $43 million Investors: Morningside Venture Investments...

...preclinical programs and support discovery efforts for the company's gene silencing and replacement THRIVE platform. Morningside Venture Investments...

...preclinical programs and support discovery efforts for the company's gene silencing and replacement THRIVE platform. Morningside Venture Investments...

...Edmond de Rothschild Investment Partners) and Bpifrance Large Venture also participated, as did Sofinnova Partners, Morningside Venture Investments...

...Edmond de Rothschild Investment Partners) and Bpifrance Large Venture also participated, as did Sofinnova Partners, Morningside Venture Investments...

...is taking its sole asset CCS1477 into the clinic next month with $26 million from Morningside Venture Investments...

...said it has raised $26 million in an undisclosed private financing round from existing investor Morningside Venture Investments...
...p300 (EP300; p300) and CREB binding protein (CREBBP; CBP). CellCentric Ltd., Little Chesterford, U.K. Mark Zipkin CCS1477 CellCentric Ltd. Morningside Venture Investments Prostate...

...said it has raised $26 million in an undisclosed private financing round from existing investor Morningside Venture Investments...
...inhibitor of E1A binding protein p300 (EP300; p300) and CREB binding protein (CREBBP; CBP). Mark Zipkin CCS1477 CellCentric Ltd. Morningside Venture Investments Prostate...

...Nanjing, China Business: Cancer, Cardiovascular Date completed: 2016-10-13 Type: Venture financing Raised: $10 million Investors: Morningside Venture Investments...